ArticleCureus2024

Pembrolizumab-Induced Insulin-Dependent Diabetes Mellitus in a Patient With Triple-Negative Breast Cancer: A Rare Immune-Related Adverse Event.

Mirac Burak Tak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.